EPA, but not DHA, decreases mean platelet volume in normal subjects

Lipids

Volumn 37, Issue 10, 2002, Pages 941-946

  Parka, Yongsoon ^a,b   Harris, William ^a,b  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b ST LUKE S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; MEDICAL APPLICATIONS; VEGETABLE OILS;

PLATLET AGGREGATION;

LIPIDS;

COLLAGEN; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; OLIVE OIL; SAFFLOWER OIL;

ADULT; ARTICLE; CELL STIMULATION; CLINICAL TRIAL; COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HEAT; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; THERMAL STIMULATION; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

ADMINISTRATION, ORAL; ADULT; BLOOD PLATELETS; BLOOD VOLUME; COLLAGEN; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; MALE; PLANT OILS; PLATELET ACTIVATION; SINGLE-BLIND METHOD; TEMPERATURE; TIME FACTORS;

CARTHAMUS TINCTORIUS; MOROCCAN PEPPER VIRUS;

EID: 0036819275     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-006-0984-1     Document Type: Article

References (47)

1. Willans, D.J., Mill, S.C., and Ranney, E.K. (1995) Common thrombotic disorders defined by CBC platelet parameters, Clin. Appl. Thrombosis Hemostasis 1, 188-201.
2. Endler, G., Klimesch, A., Sunder-Plassmann, H., Schillinger, M., Exner, M., Mannhalter, C., Jordanova, N., Christ, G. Thalhammer, R., Huber, K., and Sunder-Plassman, R. (2002) Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease, Br. J. Haematol. 117, 399-404.
3. Martin, J.F., Plumb, J., Kilbey, R.S., and Kishk, Y.T. (1983) Changes in volume and density of platelets in myocardial infarction, Br. Med. J. 287, 456-459.
4. Erne, P., Wardle, J., Sanders, K., Lewis, S.M., and Maseri, A. (1988) Mean platelet volume and size distribution and their sensitivity to agonists in patients with coronary artery disease and congestive heart failure, Thromb. Haemost. 59, 259-263.
5. Schoene, N.W. (1997) Design criteria: Tests used to assess platelet function, Am. J. Clin. Nutr. 65, 1665S-1668S.
6. Knapp, H.R. (1997) Dietary fatty acids in human thrombosis and hemostasis, Am. J. Clin. Nutr. 65, 1687S-1698S.
7. Gissi-Prevenzione Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E in 11,324 patients with myocardial infarction: Results of the GISSI-Prevenzione Trial, Lancet 354, 447-455.
8. Burr, M.L., Holliday, R.M., Fehily, A.M., and Whitehead, P.J. (1992) Haematological prognostic indices after myocardial infarction. Evidence from the Diet and Reinfarction Trial (DART), Eur. Heart J. 13, 166-170.
9. Singh, R.B., Niaz, M.A., Sharma, J.P., Kumar, R., Rastogi, V., and Moshiri, M. (1997) Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: The Indian experiment of infarct survival - 4. Cardiovasc. Drugs Ther. 11, 485-491.
10. Zucker, M.L., Trowbridge, C., Woodroof, J., Chernoff, S.B, Reynoso, L., and Dujovne, C.A. (1986) Low- vs. high-dose aspirin. Effects on platelet function in hyperlipoproteinemic and normal subjects, Arch. Intern. Med. 146, 921-925.
11. Valles, J., Santos, M.T., Aznar, J., Osa, A., Lago, A., Cosin, J., Sanchez, E., Broekman, M.J., and Marcus, A.J. (1998) Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: The effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity, Circulation 97, 350-355.
12. Brox, J., Olaussen K., Østerud, B., Elvevoll, E.O., Bjørnstad, E., Brenn, T., Brattebø, G., and Iversen, H.A (2001) Long-term sealand cod-liver-oil supplementation in hypercholesterolemic subjects, Lipids 36, 7-13.
13. Mortensen, J.Z., Schmidt, E.B., Nielsen, A.H., and Dyerberg, J. (1983) The effect of n-6 and n-3 polyunsaturated fatty acids on hemostasis, blood lipids and blood pressure, Thromb. Haemost. 50, 543-546.
14. Goodnight, S.H., Jr., Harris, W.S., and Connor, W.E. (1981) The effects of dietary omega-3 fatty acids on platelet composition and function in man: A prospective, controlled study, Blood 58, 880-885.
15. Nelson, G.J., Schmidt, P.C., and Corash, L. (1991) The effect of a salmon diet on blood clotting, platelet aggregation and fatty acids in normal adult men, Lipids 26, 87-96.
16. Wander, R.C., and Patton B.D. (1991) Comparison of three species of fish consumed as part of a western diet: Effects on platelet fatty acids and function, hemostasis, and production of thromboxane, Am. J. Clin. Nutr. 54, 326-333.
17. 2 during the hydrolysis of diacyl- and alkenylacylglycerophosphoethanolamine, Biochim. Biophys. Acta 1212, 211-216.
18. 2 receptors, J. Lipid Res. 36, 47-56.
19. Von Schacky, C., and Weber, P.C. (1985) Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans, J. Clin. Invest. 76, 2446-2450.
20. Oliver, A.E., Tablin, F., Walker N.J., and Crowe, J.H. (1999) The internal calcium concentration of human platelets increases during chilling, Biochim. Biophys. Acta 1416, 349-360.
21. Winokur, R., and Hartwig, J.H. (1995) Mechanism of shape change in chilled human platelets, Blood 85, 1796-1804.
22. Borst, C., Bos, A.N., Zwaginga, J.J., Rienks, R., de Groot, P.G., and Sixma, J.J. (1990) Loss of blood platelet adhesion after heating native and cultured human subendothelium to 100 degrees celsius, Cardiovasc. Res. 24, 665-668.
23. Thompson, C., Diaz, D., Quinn, P., Lapins, M., Kurtz, S., and Valeri, C. (1983) The role of anticoagulation in the measurement of platelet volume, Am. J. Clin. Nutr. 80, 327-332.
24. Fuhrman, B., Brook, J.G., and Aviram, M. (1986) Increased platelet aggregation during alimentary hyperlipemia in normal and hypertriglyceridemic subjects, Ann. Nutr. Metab. 30, 250-260.
25. Winterstein, G., Brook, J.G., Pillar, T., and Aviram, M. (1986) Plasma lipoproteins and platelet aggregation during alimentary lipemia. Decreased atherogenic pattern in the elderly, J. Am. Geriatr. Soc. 34, 569-572.
26. Park, Y., Schoene, N., and Harris, W. (2002) Mean platelet volume as an indicator of platelet activation: Methodological issues, Platelets 13:301-306.
27. Folch, J., Lees, M., and Sloane-Stanley, G.H. (1957) A simple method for the isolation and purification of total lipids from animal tissues, J. Biol. Chem. 226, 497-509.
28. Kojima, T., Terano, T., and Tanabe, E. (1991) Long-term administration of highly purified eicosapentaenoic acid provides improvement of psoriasis, Dermatologica 182, 225-230.
29. Negrescu, E.V., De Quintana, K.L., and Siess, W. (1995) Platelet shape change induced by thrombin receptor activation. Rapid stimulation of tyrosine phosphorylation of novel protein substrates through an integrin- and Ca(2+)-independent mechanism, J. Biol. Chem. 270, 1057-1061.
30. Sanders, T.A.B., and Hochland, M.C. (1983) A comparison of the influence on plasma lipids and platelet function of supplements of ω 3 and ω 6 polyunsaturated fatty acids, Br. J. Nutr. 50, 521-529.
31. von Schacky, C., Fischer, S., and Weber, P.C. (1985) Long-term effects of dietary marine ω-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans, J. Clin. Invest. 76, 1626-1631.
32. Hirai, A., Terano, T., Makuta, H., Kobayashi, S., Makuta, H., Ozawa, A., Fujita, T., Tamura, Y., Kitagawa, H., Kumagai, A., and Yoshida, S. (1989) Effect of oral administration of highly purified eicosapentaenoic acid and docosahexaenoic acid on platelet function and serum lipids in hyperlipidemic patients, Adv. Prostaglandin Thromboxane Leukot. Res. 19, 627-630.
33. Lillioja, S., Young, A.A., Culter, C.L., Ivy, J.L., Abbott, W.G.H., Zawadzki, J.K., Yki-Järvinen, H., Christin, L., Secomb, T.W., and Bogardus, C. (1987) Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man, J. Clin. Invest. 80, 415-424.
34. Terano, T., Hirai, A., Hamazaki, T., Kobayashi, S., Fujita, T., Tamura, Y., and Kumagai, A. (1983) Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects, Atherosclerosis 46, 321-331.
35. Nelson, G.J., Schmidt, P.S., Bartolini, G.L., Kelley, D.S., and Kyle, D. (1997) The effect of dietary docosahexaenoic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans, Lipids 32, 1129-1136.
36. Driss, F., Vericel, E., Lagarde, M., Dechavanne, M., and Darcet, P. (1984) Inhibition of platelet aggregation and thromboxane synthesis after intake of small amounts of icosapentaenoic acid, Thromb. Res. 36, 389-396.
37. Croset, M., Guichardant, M., and Lagarde, M. (1988) Different metabolic behavior of long-chain n-3 polyunsaturated fatty acids in human platelets, Biochim. Biophys. Acta 961, 262-269.
38. Dyerberg, J., Bang, H.O., Stoffersen, E., Moncada, S., and Vane, J.R. (1978) Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 23, 117-119.
39. Parent, C.A., Lagarde, M., Venton, D.L., and Le Breton, G.C. (1992) Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solublized. Platelet membranes, J. Biol. Chem. 267, 6541-6547.
40. VanRollins, M. (1995) Epoxygenase metabolites of docosahexaenoic and eicosapentaenoic acids inhibit platelet aggregation at concentrations below those affecting thromboxane synthesis, J. Pharmacol. Exp. Ther. 274, 798-804.
41. Yeo, Y.K., Philbrick, D.J., and Holub, B.J. (1989) The effect of long-term consumption of fish oil on platelet-activating factor synthesis in rat renal microsomes, Biochem. Biophys. Res. Comm. 160, 1238-1242.
42. Knofler, R., Nakano, T., Nakajima, K., and Takada, A. (1995) Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro, Thromb. Res. 78, 161-171.
43. Orth, M., Luley, C., and Wieland, H. (1995) Effects of VLDL, chylomicrons, and chylomicron remnants on platelet aggregability, Thromb. Res. 79, 297-305.
44. Broijersen, A., Karpe, F., Hamsten, A., Goodall, A.H., and Hjemdahl, P. (1998) Alimentary lipemia enhances the membrane expression of platelet P-selectin without affecting other markers of platelet activation, Atherosclerosis 137, 107-113.
45. Jakubowski, J.A., Ardlie, N.G., Chesterman, C.N., McGready, J.F., and Morgan, F.J. (1985) Acute postprandial lipaemia does not influence the in vivo activity of human platelets, Thromb. Res. 39, 725-732.
46. Hansen, K., Sickelmann, F., Pietrowsky, R., Fehm, H.L., and Born, J. (1997) Systemic immune changes following meal intake in humans, Am. J. Physiol. 273, R548-R553.
47. Nossel, H.L. (1977) Bleeding, in Principles of Internal Medicine (Thorn, G.W., Adams, R.D., Braunwald, E., Isselbacher, K.J., Petersdorf, R.G., eds.) 8th edn., pp. 294-301, McGraw-Hill Book Company, New York.